However, when we analyzed CIN, as defined by the wGII score within CSG classes in patients treated with immunotherapy, we observed that patients with high wGII is associated with improved outcome, but only in CSG-3, the groups likely harboring active cGAS-STING pathway (Supplementary Fig. S12). Here, STING1 is linked to cervical squamous intraepithelial neoplasia.